nach oben

Erschienen in:

01.09.2011 | Urology – Original Paper

Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy?

verfasst von: Maisa M. Q. Quintal, Luciana R. Meirelles, Leandro L. L. Freitas, Luis A. Magna, Ubirajara Ferreira, Athanase Billis

Erschienen in: International Urology and Nephrology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To find whether any particular method of measuring cancer extent on needle prostatic biopsies is superior to others in predicting pathological stage >T2 and biochemical recurrence following radical prostatectomy.

Materials and methods

The study was based on 168 extended biopsies and the correspondent step-sectioned surgical specimens. Tumor extent was evaluated as: (1) number and percentage of cores with carcinoma; (2) total length and percentage of cancer in mm in all cores; and (3) the greatest length and percentage of cancer in a single core.

Results

All measurements significantly predicted stage >pT2 using logistic regression. With the exception of the greatest length and percentage of cancer in a single core, all other methods were also associated with a higher risk for biochemical recurrence (Cox method). Percentage of length of carcinoma in all cores was significantly and consistently stronger than other measures in all comparisons and combined to preoperative PSA and Gleason grade in multivariate analysis gained prediction for pathologic stage >T2 and was independent of risk of biochemical recurrence.

Conclusions

Percentage of total length of carcinoma in mm in all cores of a needle biopsy had the strongest predictive positive value for stage >pT2 and risk for biochemical recurrence following radical prostatectomy. Combined with preoperative PSA and Gleason grade on biopsy may improve the predictive value for stage >pT2.

Antunes AA, Srougi M, Dall′oglio MF et al (2007) Preoperative determination of prostate cancer tumor volume: analysis through biopsy fragments. Int Braz J Urol 33:477–485PubMedCrossRef

Briganti A, Chun FK, Hutterer GC et al (2007) Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy. Eur Urol 52:733–743PubMedCrossRef

Brimo F, Vollmer RT, Corcos J et al (2008) Prognostic value of various morphometric measurements of tumor extent in prostate needle core tissue. Histopathology 53:177–183PubMedCrossRef

D’Amico AW, Whittington R, Malkowicz SB et al (1998) The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 160:2096–2101PubMedCrossRef

Sebo TJ, Cheville JC, Riehle DL et al (2001) Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer 91:2196–2204PubMedCrossRef

Lewis JS, Vollmer RT, Humprhey PA (2002) Carcinoma extent in prostate needle biopsy tissue in the prediction of whole gland tumor volume in a screening population. Am J Clin Pathol 118:442–450PubMedCrossRef

Epstein JI, Potter SR (2001) The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 166:402–410PubMedCrossRef

Goto Y, Ohori M, Arakawa A et al (1996) Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 156:1059–1063PubMedCrossRef

Grossklaus DJ, Coffey CS, Shappell SB et al (2002) Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol 167:2032–2035PubMedCrossRef

10.

Rubin MA, Bassily N, Sanda M et al (2000) Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma. Am J Surg Pathol 24:183–189PubMedCrossRef

11.

Tigrani VS, Bhargava V, Shinohara K et al (1999) Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 54:689–693PubMedCrossRef

12.

Wills ML, Sauvegeot J, Partin AW et al (1998) Ability of sextant biopsies to predict radical prostatectomy stage. Urology 51:759–764PubMedCrossRef

13.

Bismar TA, Ewis JS Jr, Vollmer RT et al (2003) Multiple measures of carcinoma extent versus perineural invasion in prostate needle biopsy tissue in prediction of pathologic stage in a screening population. Am J Surg Pathol 27:432–440PubMedCrossRef

14.

Epstein JI, Chan DW, Sokoll LJ et al (1998) Non palpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostatic specific antigen levels and needle biopsy findings. J Urol 160:2407–2411PubMedCrossRef

15.

López JI, Etxezarraga C (2006) The combination of millimeters of cancer and Gleason index in core biopsy is a predictor of extraprostatic disease. Histopathology 48:663–667PubMedCrossRef

16.

Naya Y, Slaton JW, Troncoso P et al (2004) Tumor length and location of cancer in sextant biopsy predict for side specific extraprostatic cancer extension. J Urol 171:1093–1097PubMedCrossRef

17.

Ojea Calvo A, Nuñes Lopez A, Dominguez Freire F et al (2003) Correlation of the anatomo-pathological staging of radical prostatectomy specimens with the amount of cancer in the preoperative sextant biopsy. Actas Urol Esp 27:428–437PubMed

18.

Gohji K, Okamoto M, Takenaka A et al (1999) Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate-specific antigen in Japanese men. BJU Int 83:39–42PubMedCrossRef

19.

Winkler MH, Khan FA, Kulinskaya E et al (2004) The total percentage of biopsy cores with cancer improves the prediction of pathological stage after radical prostatectomy. BJU Int 94:812–815PubMedCrossRef

20.

Capitanio U, Briganti A, Shariat SF et al (2008) The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective. Eur Urol 54:717–719PubMedCrossRef

21.

Pepe P, Fraggetta A, Galia A et al (2008) Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed? Urology 72:1198–1202PubMedCrossRef

22.

Cookson MS, Aus G, Burnett AL, Canby-Hagino ED et al (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American urological association prostate guidelines for localized prostate cancer update panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177:540–545PubMedCrossRef

23.

D’Amico AW, Whittington R, Malkowicz SB et al (2000) Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol 18:1164–1172PubMed

24.

Grossfeld GD, Latini DM, Lubeck DP et al (2002) Predicting disease recurrence in intermediate and high risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology 59:560–565PubMedCrossRef

25.

Presti JC Jr, Shinohara K, Bacchetti P et al (1998) Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology 52:1079–1084PubMedCrossRef

26.

Freedland SJ, Csathy GS, Dorey F et al (2002) Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 167:516–520PubMedCrossRef

27.

Nelson CP, Rubin MA, Strawderman M et al (2002) Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy. Urology 59:740–745PubMedCrossRef

28.

Freedland SJ, Aronson WJ, Terris MK et al (2003) The percentage of prostate needle cores with carcinoma from the more involved side of the biopsy as a predictor for prostate specific antigen recurrence after radical prostatectomy: results from the Shared equal access regional cancer hospital (SEARCH) database. Cancer 98:2344–2350PubMedCrossRef

29.

Freedland SJ, Terris MK, Csathy GS et al (2004) Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum PSA antigen. J Urol 171:2215–2220PubMedCrossRef

30.

Sebo TJ, Bock BJ, Cheville JC et al (2000) The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 163:174–178PubMedCrossRef

31.

Egawa S, Suyama K, Matsumoto K et al (1998) Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men. Urology 52:433–440PubMedCrossRef

Titel: Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy?
verfasst von: Maisa M. Q. Quintal
Luciana R. Meirelles
Leandro L. L. Freitas
Luis A. Magna
Ubirajara Ferreira
Athanase Billis
Publikationsdatum: 01.09.2011
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 3/2011
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-011-9901-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Objectives

Materials and methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2011

Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury

Adult Wilms tumour

Association between depression and malnutrition–inflammation complex syndrome in patients with continuous ambulatory peritoneal dialysis

A new technique—“lipocorticoplasty”—for the closure of partial nephrectomy defects and its comparison with the standard technique

Acute bilateral non-obstructive bacterial pyelonephritis with acute kidney injury in the elderly: role of non-invasive studies in its diagnosis